Device surgery without interruption of anticoagulation

New England Journal of Medicine

Volumn 369, Issue 16, 2013, Pages 1570-1572

  Skeith, Leslie ^a   Kovacs, Michael J ^b   Douketis, James D ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; WARFARIN; ANTICOAGULANT AGENT; HEPARIN;

ANTICOAGULANT THERAPY; BLEEDING; DEVICE THERAPY; DRUG EFFICACY; DRUG SAFETY; HEART ATRIUM FIBRILLATION; HEART VALVE SURGERY; HIGH RISK PATIENT; HUMAN; LETTER; MECHANICAL HEART VALVE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK REDUCTION; THROMBOEMBOLISM; TREATMENT DURATION; CAUTERIZATION; CLINICAL PROTOCOL; DISEASE ASSOCIATION; EMBOLISM; GAUZE DRESSING; HEMATOMA; KIDNEY FUNCTION; MEDICAL PRACTICE; MICROPUNCTURE TECHNIQUE; RISK FACTOR; SAMPLE SIZE; SURGICAL TECHNIQUE; THERAPY DELAY; ARTIFICIAL HEART PACEMAKER; FEMALE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; NOTE;

ANTICOAGULANTS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEMATOMA; HEPARIN; HUMANS; MALE; PACEMAKER, ARTIFICIAL; WARFARIN;

EID: 84885827971     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1310241     Document Type: Letter

References (5)

1. Birnie DH, Healey JS, Wells GA, et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med 2013;368:2084-93.
2. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(Suppl):e326S-e350S.
3. Skeith L, Taylor J, Lazo-Langner A, Kovacs MJ. Conservative perioperative anticoagulation management in patients with chronic venous thromboembolic disease: a cohort study. J Thromb Haemost 2012;10:2298-304.
4. Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation 2012;126:1630-9.
5. Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004;110:1658-63.